Original paper
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
Abstract
The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55-69. Knowing how the potential benefits and harms of screening vary by an individual's risk of developing prostate cancer could inform decision-making about screening at both an individual and population level. This modelling study examined the benefit-harm tradeoffs and the cost-effectiveness...
Paper Details
Title
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
Published Date
Dec 20, 2019
Journal
Volume
16
Issue
12
Pages
e1002998 - e1002998
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History